Somatropin Treatment in Patients With SHOX Deficiency and Turner Syndrome

Summary

This clinical trial will compare the mean first year height velocity of somatropin-treated prepubertal patients with SHOX deficiency with the height velocity of a control group of untreated prepubertal patients with SHOX deficiency. Both groups will be compared to a somatropin-treated group of girls with Turner syndrome. After the second year patients in the control group have the option to receive treatment as well. All patients will optionally be treated until they achieved adult height.

Timeline

Start

2000-02

Primary completion

2004-07

Completion

2010-09

Drugs

Indications

No indication recorded.